ANTI-THYMOCYTE GLOBULIN (ATG) COULD IMPROVE THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE T CELL TUMORS

被引：0
|
作者：
Chun, W. [1 ]
Shike, Y. [1 ]
Liping, W. [1 ]
Jieling, J. [1 ]
Yu, C. [1 ]
Jun, Y. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Div Hematol, Shanghai 200030, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P011
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Variable clearance of anti-thymocyte globulin (ATG) following CD34 selected allogeneic hematopoietic progenitor cell transplantation (HPCT).
    Kakhniashvili, I
    Filicko, J
    McGuire, L
    Brunner, J
    Ferber, A
    Grosso, D
    Mookerjee, B
    Stout, N
    Wagner, JL
    Zhu, ZG
    Flomenberg, N
    BLOOD, 2002, 100 (11) : 839A - 839A
  • [22] Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis
    Yang, Xue
    Li, Dongjun
    Xie, Yao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
    Meesters-Ensing, J. I.
    Admiraal, R.
    Ebskamp, L.
    Lacna, A.
    Boelens, J. J.
    Lindemans, C. A.
    Nierkens, S.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] ANTI-THYMOCYTE GLOBULIN (ATG) IN TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    RAAFAT, J
    EDELSON, RL
    BERGER, CL
    HARDY, MA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 351 - 351
  • [25] INHIBITION OF HELPER T-CELL FUNCTION BY ANTI-THYMOCYTE GLOBULIN (ATG)
    HELDERMAN, JH
    GAILIUNAS, P
    LIPSKY, P
    CLINICAL RESEARCH, 1979, 27 (02): : A327 - A327
  • [26] ANTI-THYMOCYTE GLOBULIN (ATG) EXPOSURE IS RELATED TO OVERALL SURVIVAL IN CHILDREN RECEIVING ALLOGENEIC-HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TOWARDS INDIVIDUALIZED DOSING TO IMPROVE SURVIVAL
    Admiraal, R.
    Jol-van der Zijde, C.
    van Kesteren, C.
    van Tol, M.
    Knibbe, C.
    Bredius, R.
    Boelens, J. J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S368 - S369
  • [27] Letermovir Improves the Outcome of Allogenic Stem Cell Transplantation with Anti-Thymocyte Globulin By Reducing Relapse
    Negishi, Shuto
    Miyao, Kotaro
    Ohara, Fumiya
    Wakabayashi, Hiroya
    Motegi, Kenta
    Sawa, Hitomi
    Inagaki, Yuichiro
    Sawa, Masashi
    BLOOD, 2023, 142
  • [28] Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
    Kaminski, Katie S.
    Beechinor, Ryan
    Lebovic, Rachel
    Roth, Mary
    Bangdiwala, Ananta
    Ballarini, Nicolas
    Ivanova, Anastasia
    Chong, Pearlie P.
    Jamieson, Katarzyna
    Shea, Thomas C.
    Rao, Kamakshi V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S121 - S122
  • [29] ANTI-THYMOCYTE GLOBULIN IN CONDITIONING IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A RETROSPECTIVE SINGLE CENTER ANALYSIS
    Chadievski, Lazar
    Panovska-Stavridis, Irina
    Chevreska, Lidija
    Georgievski, Borche
    Veljanovska, Aleksandra Pivkova
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 273 - 274
  • [30] Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
    Oostenbrink, Lisa V. E.
    Jol-van der Zijde, Cornelia M.
    Kielsen, Katrine
    Jansen-Hoogendijk, Anja M.
    Ifversen, Marianne
    Mueller, Klaus G.
    Lankester, Arjan C.
    van Halteren, Astrid G. S.
    Bredius, Robbert G. M.
    Schilham, Marco W.
    van Tol, Maarten J. D.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
12345